Document is current
Any future updates will be listed below
-
Authors
Nakamura, Kimitoshi
Sakai, Norio
Hossain, Mohammad Arif http://orcid.org/0000-0002-6598-7403
Eisengart, Julie B
Yamamoto, Tatsuyoshi
Tanizawa, Kazunori
So, Sairei
Schmidt, Mathias
Sato, Yuji
- License Information
-
More Information
Article History
Received: 20 August 2023
Accepted: 3 March 2024
First Online: 7 March 2024
Declarations
:
: Ethical approval was obtained from the Institutional Review Board of all seven clinical sites: Fujieda University, Fukui University, Hokkaido Medical Center, Kumamoto University, Kurume University, Ryukyu University, Saitama Medical Center, and Osaka University Hospital. The study was performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments..
: Informed consent was obtained from all individual caregivers in the study.
: KN declares speakers’ bureau fees from Sanofi, Takeda, and JCR Pharmaceuticals, as well as research funding from Sanofi, Takeda, and KM Biologics. NS reports speakers’ bureau fees from Amicus Therapeutics, Takeda, JCR Pharmaceuticals, and Sanofi, as well as research funding from JCR and Sanofi. JBE reports honoraria, advisory board fees, consulting fees, and/or research support from Actigen, Denali, JCR, Lysogene, Novel Pharma, Orchard Therapeutics, Regenxbio, Sanofi Genzyme, Sobi, and Takeda. MAH, TY, KT, SS, MS, and YS are employees of JCR Pharmaceuticals, Ltd.
